June 16, 2014 Bill Simmons, who has worked in the pharmaceutical industry for 30 years, has been named president of Jubilant HollisterStier's contract operations, replacing former CEO Marcelo Morales, who has left the company. Simmons was managing partne…
May 12, 2014 cGMP FACILITY FDA & DEA Inspected EU GMPs Compliant
• Formulation Development
• Clinical Manufacturing & Packaging
• Analytical & ICH Stability
• All Types of Dosage Forms
• Fastest Turn-Around
Contact: Dr. Math…
S. Harachand, Contributing Editor || May 1, 2014 Indian CMOs are targeting new global markets. API supplier Aurobindo, through its acquisition of Actavis assets, is moving into finished generics in Western Europe.
Helena Champion , Principal Consultant, Drug Quality Assurance LLC || May 1, 2014 Offshore CMO’s have proven a weak link in pharma’s supply chain. Will recent quality problems in India and China increase oversight?
S. Harachand, Contributing Editor || April 3, 2014 Bridging the gap between formulation and tablet manufacturing, pharmaceutical formulation intermediate (PFI) outsourcing promises sponsors time and cost reduction
Eric A. Langer, BioPlan Associates || March 7, 2014 A decade ago, there were dire concerns that the biopharmaceutical industry was headed for a severe crisis. There was, it was thought, inadequate mammalian manufacturing capacity to support the development pipeline. In particular, fears grew about sho…
Peter Pollak and Andrew Badrot, CMS Pharma || October 9, 2013 Review the business development cycle in the custom manufacturing industry and assess risks associated with pharmaceutical fine chemicals manufacturing